D.C. Zika Tests Were Flawed

Share this content:
D.C. Zika Tests Were Flawed
D.C. Zika Tests Were Flawed

FRIDAY, Feb. 17, 2017 (HealthDay News) -- Two women in Washington, D.C., were incorrectly found to be negative for Zika virus last year due to flawed testing, health officials said Thursday.

The women have given birth, but the outcomes of their pregnancies are unknown. Their doctors have been contacted, NBC News reported. D.C. health officials said all 409 specimens that tested negative between July and December will be retested by U.S. Centers for Disease Control and Prevention labs. Of the 62 specimens retested so far, two came back positive for Zika.

Of the 409 specimens, 294 were from pregnant women and 115 were from non-pregnant women or men. Retesting all of the specimens could take up to four weeks, according to NBC News.

One of the problems with the test, which was suspended Dec. 14, was a mathematical error. The district's Public Health Laboratory is working with the CDC to correct the test and start using it again, NBC News reported.

More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

Social, Communication Delays With False-Negative on M-CHAT

Social, Communication Delays With False-Negative on M-CHAT

Delays for those who pass M-CHAT screening at 18 months but are later diagnosed with ASD

FDA Approves Aimovig to Prevent Migraines

FDA Approves Aimovig to Prevent Migraines

Patients taking Aimovig reported one to two fewer monthly migraine days than those taking pacebo

Risk of Dementia Up for Older Adults With Lowest Wealth

Risk of Dementia Up for Older Adults With ...

Increased risk seen independent of education, index of multiple deprivation, health indicators

is free, fast, and customized just for you!

Already a member?

Sign In Now »